No opioids, please: Clearing the way to refuse prescriptions

March 19, 2017 by Susan Haigh

The ease of relapsing into opioid addiction has led a growing number of states to help residents make it clear to medical professionals they do not want to be prescribed the powerful painkillers.

Connecticut and Alaska are two of the latest considering legislation this year that would create a "non-opioid directive" patients can put in their medical files, formally notifying professionals they do not want to be prescribed or administered opioid medications.

Legislators in Massachusetts and Pennsylvania last year voted to create similar voluntary directives.

While patients typically have the right to make decisions about the medical care they receive and whether they want certain treatments, proponents of non-opioid directives contend such a document make a patient's wishes clear, especially in advance of medical care or if a patient becomes incapacitated. They are also seen as a way to prevent someone in addiction recovery from relapsing. The National Institute on Drug Abuse notes how exposure to drugs is one of the most common triggers for relapse.

"Whether it's in some type of directive in a treatment plan, we have a right to choose what we want in our care," said Kelvin Young, who is recovering from opioid and heroin addiction and is now director of Toivo, an alternative drug rehabilitation program in Hartford.

Such directives, however, are not a one-size-fits-all solution.

Seth Mnookin, an assistant professor at the Massachusetts Institute of Technology graduate program in science writing, acknowledged they're "not the most nuanced approach to the problem." He has written about taking opioids almost two years ago for kidney stones and a related infection, even though he previously kicked a three-year heroin addiction in 1997.

"There was no question that I needed powerful pain medication. Having a no-opioids directive in that case probably would have created a whole bunch of problems," said Mnookin, who said it felt like his "gut was being hacked at with a phalanx of rusty chisels."

During his hospital stay, Mnookin said, he repeatedly told doctors about his substance use disorder. However, he felt they weren't listening. Ultimately, he did not receive any counseling or advice regarding the risk of a potential relapse or how to guard against one. He wound up creating his own chart to ensure he didn't take too many pills.

"That's not something I think everyone is going to do," he said.

Mnookin said states should consider requiring patients with substance abuse histories to see an addiction specialist after receiving to prevent a relapse.

"In my case, I would not have written a directive," he said. "But, the fact that this legislation is being introduced means there's awareness of the necessity of having more conversations, having people outside of an addiction specialist being aware of people's histories."

Sue Kruczek, of Guilford, Connecticut, has worked to pass opioid legislation since her 20-year-old son Nick died in 2013 of a heroin overdose following an addiction to prescription drugs.

"It seems like the hospitals are unaware of the history," she said.

In Massachusetts, a patient, or the patient's guardian or health care agent, signs a one-page form that states: "I am refusing at my own insistence the offer or administration of any opioid medications including in an emergency situation where I am unable to speak for myself." The person also agrees they understand the risks of refusing and release the "from any responsibility for all consequences."

The directive, which must also be signed by the health care practitioner, became available in January. The Pennsylvania directive is still being developed.

Pennsylvania state Rep. Ed Gainey, a Democrat, proposed the directive legislation. Representing a section of Allegheny County that's seen hundreds of opioid overdose deaths over the past two years, Gainey said he sees the directive as a patients' rights issue, an opportunity to empower people who may fear relapsing into addiction, but also becoming addicted.

"My whole thing is, 'how can we give patients more control over their destiny?'" he said. "A lot of people are more aware now and while they're more aware, it's good that we let them know they have an option to opt out and not receive ."

Explore further: Many patients receive prescription opioids during treatment for opioid addiction

Related Stories

Many patients receive prescription opioids during treatment for opioid addiction

February 23, 2017
More than two in five people receiving buprenorphine, a drug commonly used to treat opioid addiction, are also given prescriptions for other opioid painkillers - and two-thirds are prescribed opioids after their treatment ...

Opioid dependence can start in just a few days

March 16, 2017
(HealthDay)—Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests.

Drug overdose deaths increase significantly in past five years

December 16, 2016
Drug overdose deaths have increased by 33 percent in the past five years across the country, with some states seeing jumps of nearly 200 percent.

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Medical field urged to look within for solution to opioid addiction

September 16, 2014
University of Cincinnati (UC) researchers are asking the medical community to consider its own role in the rise in prescription opioid abuse, calling for more research on iatrogenic addiction (addiction resulting from medical ...

Physician calls for better understanding, policy and treatment for opioid addiction

November 28, 2016
The U.S. opioid epidemic has evolved so much in the last four years that current federal policy responses risk diminishing returns in saving human lives, according to a new peer-reviewed perspective by University of Alabama ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.